Literature DB >> 25903649

Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina.

Julia V Busik1, Maria B Grant2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25903649      PMCID： PMC4428600          DOI： 10.1161/ATVBAHA.115.305395

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  13 in total

Review 1.  Anti-vascular endothelial growth factor for diabetic macular oedema.

Authors:  Gianni Virgili; Mariacristina Parravano; Francesca Menchini; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2014-10-24

2.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

3.  The role of O-linked sugars in determining the very low density lipoprotein receptor stability or release from the cell.

Authors:  J Magrané; R P Casaroli-Marano; M Reina; M Gåfvels; S Vilaró
Journal:  FEBS Lett       Date:  1999-05-14       Impact factor: 4.124

Review 4.  Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.

Authors:  Gianni Virgili; Mariacristina Parravano; Francesca Menchini; Massimo Brunetti
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

5.  Receptor heterodimerization as a novel mechanism for the regulation of Wnt/β-catenin signaling.

Authors:  Kyungwon Lee; Younghwa Shin; Rui Cheng; Kyoungmin Park; Yang Hu; Jeffrey McBride; Xuemin He; Yusuke Takahashi; Jian-Xing Ma
Journal:  J Cell Sci       Date:  2014-09-30       Impact factor: 5.285

6.  Wnt signaling mediates pathological vascular growth in proliferative retinopathy.

Authors:  Jing Chen; Andreas Stahl; Nathan M Krah; Molly R Seaward; Roberta J Dennison; Przemyslaw Sapieha; Jing Hua; Colman J Hatton; Aimee M Juan; Christopher M Aderman; Keirnan L Willett; Karen I Guerin; Akiko Mammoto; Matthew Campbell; Lois E H Smith
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

7.  Pegaptanib for neovascular age-related macular degeneration.

Authors:  Evangelos S Gragoudas; Anthony P Adamis; Emmett T Cunningham; Matthew Feinsod; David R Guyer
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

8.  Mouse model of subretinal neovascularization with choroidal anastomosis.

Authors:  John R Heckenlively; Norman L Hawes; Martin Friedlander; Steven Nusinowitz; Ronald Hurd; Muriel Davisson; Bo Chang
Journal:  Retina       Date:  2003-08       Impact factor: 4.256

9.  Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation.

Authors:  Chao Li; Zhong Huang; Ronald Kingsley; Xiaohong Zhou; Feng Li; David W Parke; Wei Cao
Journal:  Arch Ophthalmol       Date:  2007-06

10.  Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.

Authors:  Anja Lux; Helene Llacer; Florian M A Heussen; Antonia M Joussen
Journal:  Br J Ophthalmol       Date:  2007-05-30       Impact factor: 4.638
View more
  2 in total

1.  Oxidative stress upregulates Wnt signaling in human retinal microvascular endothelial cells through activation of disheveled.

Authors:  Chi Zhang; Elizabeth Tannous; Jie J Zheng
Journal:  J Cell Biochem       Date:  2019-04-08       Impact factor: 4.429

Review 2.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.